Taking Part in Cancer Research
Doctors all over the country are conducting many types of clinical trials (research studies in which people volunteer to take part). Clinical trials are designed to answer important questions and to find out whether new approaches are safe and effective.
Research already has led to advances, and doctors continue to search for more effective methods for treating Hodgkin lymphoma. Doctors are studying methods of new and better ways to treat it, and ways to improve quality of life.
People who join clinical trials may be among the first to benefit if a new approach is effective. And even if people in a trial do not benefit directly, they still make an important contribution by helping doctors learn more about Hodgkin lymphoma and how to control it. Although clinical trials may pose some risks, doctors do all they can to protect their patients.
If you are interested in being part of a clinical trial, talk with your doctor. You may want to read the NCI booklet Taking Part in Cancer Treatment Research Studies. This booklet describes how treatment studies are carried out and explains their possible benefits and risks.
NCI's Web site includes a section on clinical trials at http://www.cancer.gov/clinicaltrials. It has general information about clinical trials as well as detailed information about specific ongoing studies of Hodgkin lymphoma. Information specialists at 1-800-4-CANCER and at LiveHelp (https://livehelp.cancer.gov) can answer questions and provide information about clinical trials.
This text may be reproduced or reused freely. Please credit the National Cancer Institute as the source. Any graphics may be owned by the artist or publisher who created them, and permission may be needed for their reuse.